Back
Day Range
$47.00
$49.18
52-Week Range
$6.71
$53.65
Volume
512,668
50D / 200D Avg
$45.69
/
$29.72
Prev Close
$48.03
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 45.1 | 14.0 |
| P/B | 12.0 | 2.4 |
| ROE % | 50.5 | 11.4 |
| Net Margin % | 31.2 | 10.1 |
| Rev Growth 5Y % | — | 7.0 |
| D/E | 0.1 | 0.5 |
Key Takeaways
ROE of 50.47% indicates high profitability
Net margin of 31.18% shows strong profitability
Debt/Equity of 0.14 — conservative balance sheet
Generating 74.81M in free cash flow
P/E of 45.14 — premium valuation
Cash machine — converts 143.22% of earnings into free cash flow
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
50.47%
ROIC19.32%
Net Margin31.18%
Op. Margin34.38%
Safety
Debt / Equity
0.14
Current Ratio9.76
Interest Coverage0.00
Valuation
P/E Ratio
45.14
P/B Ratio11.97
EV/EBITDA37.99
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 167.50M | Net Income (TTM) | 52.23M |
| ROE | 50.47% | ROA | 21.71% |
| Gross Margin | 100.00% | Operating Margin | 34.38% |
| Net Margin | 31.18% | Free Cash Flow (TTM) | 74.81M |
| ROIC | 19.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 9.76 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 45.14 | P/B Ratio | 11.97 |
| P/S Ratio | 14.08 | PEG Ratio | -0.13 |
| EV/EBITDA | 37.99 | Dividend Yield | 0.00% |
| Market Cap | 2.36B | Enterprise Value | 2.19B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 167.50M | 0.0 | 0.0 |
| Net Income | 52.23M | -100.42M | -114.94M |
| EPS (Diluted) | 0.08 | -2.29 | -2.63 |
| Gross Profit | 167.50M | 0.0 | 0.0 |
| Operating Income | 57.59M | -98.55M | -111.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 240.54M | 71.50M | 149.96M |
| Total Liabilities | 43.64M | 61.45M | 48.51M |
| Shareholders' Equity | 196.90M | 10.05M | 101.44M |
| Total Debt | 26.63M | 49.62M | 32.06M |
| Cash & Equivalents | 196.81M | 29.16M | 99.92M |
| Current Assets | 201.67M | 34.11M | 106.15M |
| Current Liabilities | 20.67M | 16.32M | 20.78M |